Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Retropsoas Technologies has developed the EARP Interbody System, a Class II FDA-cleared intervertebral body fusion device for lumbar spinal fusion. The company is also conducting a clinical trial to evaluate its Endoscopic Assisted Retropsoas (EARP) Nerve Cuff Electrode and Retractor system to improve intraoperative neurophysiological monitoring during TLIF surgeries. The trial is currently recruiting and aims to compare the safety and effectiveness of this novel approach versus standard nerve monitoring tools[1][3][4].
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Retropsoas Technologies.